Changes in GABA Levels and Secondary Bile Acids in Guillain-Barré Syndrome

Overview

This study investigates the relationship between gut microbiota and serum metabolites in Guillain-Barré syndrome (GBS), revealing significant alterations in GABA and secondary bile acid levels. The findings suggest a potential link between gut dysbiosis and the pathophysiology of GBS.

Background

Guillain-Barré syndrome (GBS) is an acute, immune-mediated inflammatory disease affecting the peripheral nervous system, often triggered by infections. Understanding the role of gut microbiota in GBS is crucial, as emerging evidence indicates that dysbiosis may influence immune responses and metabolic pathways associated with this condition. This study aims to elucidate the metabolic and microbial changes in GBS patients compared to healthy controls.

Data Highlights

Key Findings

• GABA levels were significantly increased in GBS subjects.
• Multiple secondary bile acids were significantly decreased in GBS subjects.
• Specific gut bacteria, including Ligilactobacillus salivarius and Klebsiella pneumoniae, were more abundant in GBS patients.
• Correlation analysis indicated that changes in GABA were associated with specific gut microbes.
• Pathogens such as K. pneumoniae were isolated from GBS stool samples.

Clinical Implications

The significant alterations in GABA and secondary bile acids in GBS patients suggest potential biomarkers for diagnosis and therapeutic targets. Modulating gut microbiota may offer new avenues for influencing the clinical course of GBS.

Conclusion

The study highlights the disruption of GABA metabolism and secondary bile acid pathways in GBS, linking these changes to gut dysbiosis and suggesting implications for diagnosis and treatment.

Related Resources & Content

1. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome - Doorn - 2023 - European Journal of Neurology - Wiley Online Library
2. Exploring GABA Signaling Pathways within the Brain-Gut-Microbiome Interconnection
3. Association of the triglyceride-glucose index with the severity and short-term prognosis of Guillain-Barré syndrome
4. Comprehensive Analysis of Antibody Responses to Glycolipids in Individuals Diagnosed with Guillain-Barré Syndrome
5. Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases
6. Guillain–Barré syndrome | Nature Reviews Disease Primers
7. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome - Doorn - 2023 - European Journal of Neurology - Wiley Online Library
8. Guillain–Barré syndrome | Nature Reviews Disease Primers